New developments in the treatment of acute bacterial skin and skin structure infections: considerations for the effective use of dalbavancin

New developments in the treatment of acute bacterial skin and skin structure infections: considerations for the effective use of dalbavancin

Janelle J Juul, Caitlin F Mullins, William J Peppard, Angela M Huang Department of Pharmacy, Froedtert & the Medical College of Wisconsin, Milwaukee, WI, USA Abstract: Dalbavancin, an intravenous glycopeptide, was approved by the US Food and Drug Administration in May 2014 for use in adult...

Full description

Bibliographic Details
Main Authors: Juul JJ, Mullins CF, Peppard WJ, Huang AM
Format: Article
Language:English
Published: Dove Medical Press 2016-02-01
Series:Therapeutics and Clinical Risk Management
Subjects:
Acute bacterial skin and skin structure infections
skin and soft tissue infections
dalbavancin
glycopeptide
Online Access:https://www.dovepress.com/new-developments-in-the-treatment-of-acute-bacterial-skin-and-skin-str-peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/new-developments-in-the-treatment-of-acute-bacterial-skin-and-skin-str-peer-reviewed-article-TCRM

Similar Items